Zoetis company profile

ZTS · NYSE · USD

Compare Zoetis
$83.48Change from previous close: −1.08%Absolute change: −$0.91

Close · November 17, 2026

Company profile

Zoetis has 14,500 employees and is headquartered in Parsippany, United States.

Based in Parsippany, New Jersey, Zoetis was founded in 1952 and works in animal health, covering the discovery, development, manufacture and sale of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision animal health solutions. Its products are aimed mainly at companion animals such as dogs, cats and horses, and at livestock including cattle, swine, poultry, fish and sheep, and are marketed to veterinarians, livestock producers and pet owners. The range includes parasiticides, vaccines, dermatology products, anti-infectives, pain and sedation treatments, point-of-care diagnostics, rapid immunoassay tests and blood glucose monitors, as well as nutritional products. The company sells in the United States and in other markets worldwide, and it collaborates with Blacksmith Medicines to develop novel antibiotics for animal health.

In the fiscal year ended December 2025, Zoetis reported revenue of 9.5 billion US dollars, up 2.3% from the previous year, and net income of 2.7 billion US dollars. The company employed 14,500 people at the end of the period.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Headquarters
10 Sylvan Way, 07054, Parsippany
Employees
14,500
Chief executive
Kristin Peck
Founded
1952
Fiscal year
January - December
Listing
ZTS · NYSE
Indices
S&P 500
Currency
USD
ISIN
US98978V1035
Website
zoetis.com

Zoetis and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
ZoetisZTSUnited States$33.92B14,50037.9%14.1
United TherapeuticsUTHRUnited States$25.04B1,40039.4%22.2
ViatrisVTRSUnited States$23.58B30,000——
Teva Pharmaceutical IndustriesTEVAUnited States$49.67B31,17319.8%99.0
Neurocrine BiosciencesNBIXUnited States$16.73B2,50026.6%24.5
Hims & Hers HealthHIMSUnited States$4.13B2,442-6.4%—

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Zoetis with its competitors